Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
Lam Research (LRCX) reported an insider transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at $0. Following the transaction, the director beneficially owned 5,322 shares directly and 560 shares indirectly via a trust. The reported direct amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX) director reported the acquisition of 1,635 shares of common stock at $0 on 11/07/2025, according to a Form 4.
Following the transaction, the reporting person beneficially owned 9,135 shares, held in direct ownership. The filing notes this amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX): A company director reported an equity grant on a Form 4. On 11/07/2025, the director acquired 1,635 shares of common stock at $0, typically reflecting a stock or restricted stock unit award. Following this transaction, the director beneficially owned 191,375 shares.
The reported total includes shares subject to unvested restricted stock units, and the ownership is listed as direct.
Lam Research (LRCX) filed a Form 4 reporting insider activity. A director acquired 1,635 shares of common stock at a price of $0 on 11/07/2025. Following this transaction, the director’s beneficial ownership stands at 5,342 shares, held directly.
The footnote states the reported amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX) disclosed an insider equity transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at a reported price of $0, consistent with an equity award. Following the transaction, the director beneficially owned 288,705 shares. The filing notes that this amount includes shares subject to unvested restricted stock units.
LAM Research (LRCX) reported an insider transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at $0.
After the transaction, the director beneficially owned 109,995 shares, held directly. The reported total includes shares subject to unvested restricted stock units.
Lam Research (LRCX) reported director insider activity. On 11/06/2025, the director transferred 2,950 common shares to the Sohail Family Trust at $0 (Code G), shifting those holdings from direct to indirect. Following the transfer, direct ownership for that lot moved to 0, while the trust held 33,580 shares indirectly. The reporting person remains the beneficial owner of the securities held by the trust.
On 11/07/2025, the director acquired 1,635 common shares at $0 (Code A), bringing direct beneficial ownership to 1,635. The reported totals include shares subject to unvested restricted stock units.
Lam Research Corporation filed a Form S-8 to register up to 96,800,000 shares of its common stock, par value $0.001 per share, issuable pursuant to the Lam Research Corporation 2025 Stock Incentive Plan. These shares may be issued as equity compensation to eligible participants under the plan.
The filing also outlines standard Delaware indemnification provisions for directors and officers, and includes exhibits such as the 2025 Plan, legal opinion, auditor consent, and filing fee table.
Lam Research (LRCX) reported results of its Nov 4, 2025 annual meeting. Stockholders approved the Lam 2025 Stock Incentive Plan and an amendment to the Restated Certificate of Incorporation to limit the liability of certain officers to the fullest extent permitted by Delaware law. The amendment became effective upon filing with Delaware on November 4, 2025, and the company also filed a Restated Certificate that integrated prior amendments.
All director nominees were elected. “Say on Pay” was approved with 90.83% of votes cast. The new stock plan was approved with 93.79% of votes cast. KPMG LLP was ratified as independent auditor with 99.35% of votes cast. A shareholder proposal on special meeting rights received 41.36% support and was not approved.
Lam Research (LRCX) director reported a sale of 1,298 shares of common stock on 11/03/2025 at $159.99 per share (Transaction Code S). The trade was made pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024.
After the sale, the reporting person beneficially owned 1,652 shares directly and 28,930 shares indirectly held by a trust.